1.5400
-0.0400
(-2.53%)
At close: January 30 at 4:00:01 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| FOSTER JONATHAN P. Chief Financial Officer | Conversion of Exercise of derivative security | Jun 21, 2024 | 11,363 |
| GEORGE ROBERT E Director | Purchase | Dec 26, 2023 | 14,660 |
| KLEMP WALTER V Chief Executive Officer | Conversion of Exercise of derivative security | Jul 2, 2024 | 57,035 |
| PICKER DONALD H Officer | Conversion of Exercise of derivative security | Jun 21, 2024 | 8,001 |
Related Tickers
THAR Tharimmune, Inc.
1.9800
0.00%
FRTX Fresh Tracks Therapeutics, Inc.
0.9330
+0.32%
PULM Pulmatrix, Inc.
7.67
-1.79%
ENSC Ensysce Biosciences, Inc.
6.71
-3.03%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.7300
+2.37%
BPTH Bio-Path Holdings, Inc.
0.8159
+4.47%
IKNA Ikena Oncology, Inc.
1.4900
-0.67%
LYEL Lyell Immunopharma, Inc.
0.5832
+0.59%
CSCI COSCIENS Biopharma Inc.
2.7700
+2.21%
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%